US Department of health sued Gilead for infringement of CDC patent
-
Last Update: 2019-11-08
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Today, the U.S Department of health filed a lawsuit in court accusing Gilead science of violating a patent for CDC use in 2015 by using its HIV drugs truvada and descent for pre infection prevention (PREP) The health minister said that while Gilead's drugs have saved lives of AIDS patients, they should also respect the U.S patent system, the work of CDC scientists, and tax payers Gilead said that the use of these antiviral drugs in prep is not an invention of CDC, which has no patent It said Geely spent $1.1 billion to develop truvada, and CDC's investment was negligible Truvada, with $3 billion in sales last year, is Geely's mainstay Today Gilead is down 2%.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
